Yoga Nidra and Preksha Meditation for Mixed Anxiety and Depression Condition

Phase 3

Not yet recruiting

• Conditions: Other mixed anxiety disorders, (2) ICD-10 Condition: F413||Other mixed anxiety disorders,

• Registration Number: CTRI/2021/09/036110
• Lead Sponsor: UGC FELLOWSHIP AND CONTINGENCY

Brief Summary

The research work is based on the patients suffering from MADD visiting to Sir Sundarlal Hospital, BHU, Varanasi under the supervision of Prof. J. S. Tripathi & Co- Supervision of 1. Prof. J.S. Yadav Department of Psychiatry IMS, BHU & 2. Prof. S. K. Dwivedi, Department of Sanskrit, Faculty of Arts, BHU. This is an interventional type of study in which two Yogic Interventions viz Yoga Nidra & Preksha Meditation has been selected. Study is being conducted on 150 patients randomly divided into 3 groups.

Diagnosed cases of MADD are  being registered from O.P.D. of Division of Manas Rog (Neuro – Psychiatry & Psychosomatic Medicine), Deptt. of Kayachikitsa, Sir Sundar Lal Hospital, I.M.S., B.H.U., Varanasi. DASS-42 Scale and WHO Quality of Life Bref Assessment Parameters are being used  for assessment of  anxiety and depression and quality of life of the patients of MADD.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2021-08-28
• Study Start: 2021-09-16

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

• 1.Newly Diagnosed Patients fulfilling the diagnostic criteria of MADD according to DSM-4.
• Age range between 20-60 years belonging to either sex.
• Patients giving the informed consent.

Exclusion Criteria

• 1.Patients who have undergone treatment with MAO inhibitors or any other SSRI antidepressants 2.
• Patients with prior history of seizures.
• 3.Psychiatric diseases resembling clinical presentation of MADD like Major Depressive Disorder, Dysthymic Disorder, panic Disorder, or Generalized Anxiety Disorder.
• Patients having history of chronic illnesses such as Asthma, Tuberculosis and AIDS etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduction of the scores of	90 days
Improvement into the clinical signs and symptoms.	90 days
DASS. Improvement of the scores of WHO Quality of Life.	90 days

Secondary Outcome Measures

Name	Time	Method
Positive and promotive improvement in the mental health	90 days

Trial Locations

Locations (1)

SS HOSPITAL BHU; 🇮🇳 Varanasi, UTTAR PRADESH, India

SS HOSPITAL BHU

🇮🇳Varanasi, UTTAR PRADESH, India

PRIYANKA KUMARI

Principal investigator

7991153209

anajitu@gmail.com